I think I recall a couple of years ago there was a study that was shown, respected, and you probably know it better than I, that $2 million for gene therapy for ultra-rare diseases...
Very concisely, how are we going to show restraint on the price of some of these new gene therapies?
somebody is paying. Yes, insurance is making it more affordable. Medicaid is making it more affordable. Medicare is maki...
If you are telling voters you are going to do something when you know at the get go you have no legislative solution whi...
We support legislation in order to be able to do value based contracts in the case of gene therapy.
It is kind of following a formula. Republicans--we publicly attack private--I don't but others, publicly attack private ...
Let's just be clear, everybody on this panel cares about the high cost of prescription drugs and wants to work on real s...
Have you had a chance to evaluate the bill that is working its way through Judiciary Committee?
I have been concerned that we don't really know how we are going to price those.
without the profit incentive, you will not get the innovation.
If you have got an initial high price, no matter what your value-based purchasing arrangement is, it could still be some...